3-Methoxybenzamide
CAS No. 5813-86-5
3-Methoxybenzamide( 3-MBA )
Catalog No. M20861 CAS No. 5813-86-5
3-Methoxybenzamide is a competitive inhibitor of poly(ADP-ribose) synthetase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 33 | In Stock |
|
| 50MG | 52 | In Stock |
|
| 100MG | 75 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 193 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Methoxybenzamide
-
NoteResearch use only, not for human use.
-
Brief Description3-Methoxybenzamide is a competitive inhibitor of poly(ADP-ribose) synthetase.
-
Description3-Methoxybenzamide is a competitive inhibitor of poly(ADP-ribose) synthetase.
-
In Vitro3-Methoxybenzamide (0-30 mM) affects septation via the FtsZ system during both vegetative growth and sporulation.3-Methoxybenzamide (3 MB; 0.2 to 0.6 mM) significantly increaseS the growth and microtuber formation of in vitro propagated plants.Cell Viability Assay Cell Line:ftsZ mutant strains.Concentration:0-30 mM.Incubation Time:30℃ overnight.Result:Changes directly or indirectly the ability of ftsZ to bind or hydrolyze the guanine nucleotide, ultimately leading to the inhibition of Zring formation.
-
In Vivo——
-
Synonyms3-MBA
-
PathwayMetabolic Enzyme/Protease
-
TargetTransferase
-
Recptorpoly(ADP-ribose) synthetase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5813-86-5
-
Formula Weight151.16
-
Molecular FormulaC8H9NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:30mg/mL(198.47mM)
-
SMILESCOc1cccc(C(N)=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ohashi Y Chijiiwa Y Suzuki K et al. The Lethal Effect of a Benzamide Derivative 3-Methoxybenzamide Can Be Suppressed by Mutations within a Cell Division Gene ftsZ in Bacillus subtilis[J]. Journal of Bacteriology 1999 181(4):1348-51.
molnova catalog
related products
-
CBHcy
CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
-
BQCA
BQCA a highly selective allosteric modulator of the M1 mAChR.
-
CP-609754
CP-609754 shows selective inhibition of farnesyltransferase.
Cart
sales@molnova.com